Document Detail


Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells.
MedLine Citation:
PMID:  10794846     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Alzheimer's disease cybrid cells produced by replacing endogenous mitochondria in human neuroblastoma SH-SY5Y cells with platelet mitochondria from subjects with Alzheimer's disease have higher levels of reactive oxygen species than do cybrid cells with mitochondria from control subjects. These cells were used to test if this chronic mild increase in reactive oxygen species affects muscarinic receptor-coupled signaling activities. Basal and carbachol-stimulated phosphoinositide hydrolysis were higher, and there was less inhibition by glutathione depletion, in Alzheimer's disease than control cybrid cells. Elevated phosphoinositide hydrolysis in Alzheimer's disease cybrid cells also was evident upon direct activation of G-proteins (Gq/11) linked to phosphoinositide signaling or of phospholipase C, but immunoblot analyses revealed equivalent levels of Gq/11 and phospholipase C in both cell lines. These results indicate that there is up-regulation of phosphoinositide signaling in Alzheimer's disease cybrid cells in association with chronic mild oxidative stress, although treatment of cells with H(2)O(2) to induce greater acute oxidative stress caused decreases in carbachol-stimulated phosphoinositide hydrolysis that were similar in Alzheimer's disease and control cybrid cells. In contrast to phosphoinositide hydrolysis, carbachol-stimulated AP-1 DNA binding activity was lower in Alzheimer's disease than control cybrid cells, and this deficit was associated with deficient protein kinase C-mediated activation of AP-1. Overall, these results demonstrate that chronically elevated reactive oxygen species in Alzheimer's disease cybrid cells are associated with a more robust phosphoinositide signaling system, but lower signaling to activation of AP-1. These alterations may represent adaptations to exposure to oxidants, which precede more widespread deficits in signaling associated with more severe oxidative stress.
Authors:
P De Sarno; G N Bijur; R Lu; R E Davis; R S Jope
Related Documents :
15522966 - Cell-density-dependent regulation of neural precursor cell function.
8088316 - The gold anti-rheumatic drug auranofin governs t cell activation by enhancing oxygen fr...
3084496 - Patterns of destruction of mouse neuroblastoma cells by extracellular hydrogen peroxide...
15757366 - Porphyrin-fullerene c60 dyads with high ability to form photoinduced charge-separated s...
12657516 - A positive immunoselection method to isolate villous cytotrophoblast cells from first t...
21966426 - Fine-tuning roles of endogenous brain-derived neurotrophic factor, trkb and sortilin in...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neurobiology of aging     Volume:  21     ISSN:  0197-4580     ISO Abbreviation:  Neurobiol. Aging     Publication Date:    2000 Jan-Feb
Date Detail:
Created Date:  2000-07-07     Completed Date:  2000-07-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8100437     Medline TA:  Neurobiol Aging     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  31-8     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Sparks Center 1057, Birmingham, AL 35294-0017, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / metabolism*,  pathology
Buthionine Sulfoximine / pharmacology
Carbachol / pharmacology
Cells, Cultured
Cholinergic Agonists / pharmacology
DNA / metabolism
Enzyme Inhibitors / pharmacology
GTP-Binding Proteins / metabolism
Glutathione / metabolism
Humans
Hybrid Cells / cytology,  metabolism*
Hydrogen Peroxide / pharmacology
Hydrolysis / drug effects
Mitochondria / metabolism,  transplantation
Oxidative Stress / drug effects
Phosphatidylinositols / metabolism*
Protein Kinase C / metabolism
Reactive Oxygen Species / metabolism
Receptors, Muscarinic / metabolism*
Signal Transduction / drug effects
Transcription Factor AP-1 / metabolism*
Type C Phospholipases / metabolism
Grant Support
ID/Acronym/Agency:
AG06569/AG/NIA NIH HHS; NS10795/NS/NINDS NIH HHS; NS37768/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/Cholinergic Agonists; 0/Enzyme Inhibitors; 0/Phosphatidylinositols; 0/Reactive Oxygen Species; 0/Receptors, Muscarinic; 0/Transcription Factor AP-1; 5072-26-4/Buthionine Sulfoximine; 51-83-2/Carbachol; 70-18-8/Glutathione; 7722-84-1/Hydrogen Peroxide; 9007-49-2/DNA; EC 2.7.11.13/Protein Kinase C; EC 3.1.4.-/Type C Phospholipases; EC 3.6.1.-/GTP-Binding Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly...
Next Document:  Microglia, amyloid and dementia in alzheimer disease. A correlative study.